Form 8-K - Current report:
SEC Accession No. 0001140361-25-022001
Filing Date
2025-06-10
Accepted
2025-06-10 06:02:16
Documents
12
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20050437_8k.htm   iXBRL 8-K 42657
  Complete submission text file 0001140361-25-022001.txt   169778

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20250605.xsd EX-101.SCH 3856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20250605_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20250605_pre.xml EX-101.PRE 16038
14 EXTRACTED XBRL INSTANCE DOCUMENT ef20050437_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 251035872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)